PQM+ is working with Liberia’s Medicines and Health Products Regulatory Authority (LMHRA) to build its capacity to carry out regulatory functions. PQM+ supported LMHRA to develop a five-year strategic plan (2021-2025) to strengthen the governance of the medical product quality assurance system. The LMHRA’s board of directors, representing the Ministry of Health, School of Pharmacy, Ministry of Justice, Ministry of Commerce, and the Consumers Groups Association, validated the plan in 2021.
In addition, the program is helping draft regulations to strengthen LMHRA’s enforcement actions and the registration and importation of medicines, as well as improve the national quality control laboratory’s ability to undertake post-marketing surveillance to monitor the quality of medical products in circulation and boost its own revenue stream.
Impact stories and news
- PQM+ works to strengthen Liberia’s regulatory authority
- Ensuring Quality Tools to Fight Malaria
- PQM+ supports risk-based post-marketing surveillance for antimalarial and MCH medicines
- Liberia improves cost efficiency of medicines quality testing
- LMHRA finalizes a strategic plan to strengthen governance of medical product quality
Office
Monrovia, Liberia
